Showing results (11-20 of 352) with videos related to
Sort By:
Pageof 36
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Treatment Options for Acute GoutBrian W Coburn, Ted R MikulsCurrent Opinion in Rheumatology|April 20, 2005
Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of preventionMarcus H Snow, Ted R MikulsCurrent Opinion in Rheumatology|February 8, 2006
New insights into gout epidemiologyTed R Mikuls, Kenneth G SaagCurrent Rheumatology Reports|October 5, 2007
Switching anti-TNF-alpha agents: what is the evidence?Alan R Erickson, Ted R MikulsCurrent Rheumatology Reports|May 28, 2005
Recent advances in the epidemiology of goutKenneth G Saag, Ted R MikulsCurrent Rheumatology Reports|October 9, 2003
Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritisTed R Mikuls, Arthur L WeaverThe American Journal of Managed Care|November 23, 2005
Understanding treatments for goutAmy C Cannella, Ted R MikulsCurrent Opinion in Rheumatology|February 21, 2018
Recent advances in the treatment of rheumatoid arthritisTina D Mahajan, Ted R MikulsDrug Safety|December 24, 2002
Benefit-risk assessment of infliximab in the treatment of rheumatoid arthritisTed R Mikuls, Larry W MorelandCurrent Rheumatology Reports|May 28, 2005
Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?Ted R Mikuls, Kenneth G SaagPageof 36